Brief: Xintela Gets Notice Of Allowance From USPTO For Quality Assurance Of Chondrocyte-Based Products

Xintela AB

29/07/2020 07:52

July 29 (Reuters) - Xintela AB  XINT.ST :
    * XINTELA RECEIVES NOTICE OF ALLOWANCE FROM USPTO FOR
QUALITY
ASSURANCE OF CHONDROCYTE-BASED PRODUCTS
    * ONCE GRANTED, PATENT WILL BE VALID UNTIL 2038.
    * NOTICE OF ALLOWANCE MEANS THAT USPTO INTENDS TO GRANT
PATENT
AFTER CERTAIN FORMAL STEPS HAVE BEEN COMPLETED.

Source text for Eikon:  ID:nBQNK3Mff 
Further company coverage:  XINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))